Medifast (MED) Change in Receivables (2010 - 2021)

Medifast has reported Change in Receivables for 12 years, with the latest figure at -$496000.0 in Q1 2021.

• For the quarter ending Q1 2021, Change in Receivables rose 52.63% year-over-year to -$496000.0; the trailing twelve-month figure through Mar 2021 stood at $254000.0 (down 92.52% YoY), and the FY2020 full-year result was -$297000.0, down 107.31% from the prior year.
• Change in Receivables for Q1 2021 stood at -$496000.0, down from -$15000.0 in the prior quarter.
• The five-year high for Change in Receivables was $3.7 million in Q3 2019, with the low at -$1.0 million in Q1 2020.
• Historically, Change in Receivables has averaged $208411.8 across 5 years, with a median of $19000.0 in 2017.
• Annual changes were most pronounced in 2018 — Change in Receivables jumped 2057.89% — and 2019, when it plunged 251.85%.
• Medifast's Change in Receivables stood at $19000.0 in 2017, then jumped by 2057.89% to $410000.0 in 2018, then rose by 1.22% to $415000.0 in 2019, then sank by 103.61% to -$15000.0 in 2020, then slumped by 3206.67% to -$496000.0 in 2021.
• The last three Change in Receivables figures came in at -$496000.0 (Q1 2021), -$15000.0 (Q4 2020), and $319000.0 (Q3 2020), per Business Quant data.